Our first paper in 2022 ! #EndovascularRobotics @TJUHNeurosurg @TJUHospital @JeffersonUniv

The Microbot team has been working tirelessly this Summer, achieving key milestones and building momentum with the LIBERTY® Endovascular Robotic System. Every step brings us closer to transforming the future of endovascular care #robotictech. #MBOTnews #endovascularrobotics

Harel Gadot and Rachel Vaknin will be attending the @HCWCO 27th Annual Global Investment Conference, bringing together innovators, investors, and industry leaders. Meet us there to learn how $MBOT is redefining #endovascularrobotics. https://t.co/9hNreUsT7I #LifeSciencesInvestor

Major Milestone Achieved! Microbot Medical’s LIBERTY® Endovascular Robotic System has officially received FDA clearance! Read more: https://t.co/BkmoPWTxOt #FDAClearedMBOT #FDA #endovascularrobotics #MBOTnews

#SCRN2023 is off to a great start! Fascinating learning from Dr. Myriam Curet on @IntuitiveSurg's path to success & from Dr. Avi Fischer on the dramatic robotics-driven healthcare transformation. Proud to pioneer #EndovascularRobotics.🚀 @scrnaonline #Epeeps #EPFellows #MedTech

Via @GreenJournal: A look at broad range of recent advances and future directions in #StrokeDiagnostics, #EndovascularRobotics, and #Neuromodulation. https://t.co/lTsfCqg9sr #NeuroTwitter

ICYMI: Microbot Medical received a non-dilutive grant to strengthen our manufacturing capabilities as we continue commercial readiness plans for the LIBERTY® System. With every milestone, we’re advancing the future of #endovascularrobotics. https://t.co/EeqZa5hwlr #medtech

Microbot is working to redefine #endovascularrobotics with systems that are compact, disposable, and simple to operate—breaking down the barriers of traditional robotics.

We're hiring! Join Microbot Medical as a U.S. Area #SalesManager and help shape the future of #endovascularrobotics. Apply now! https://t.co/O1n3ckyUmB

What improves access to care? Minimally invasive #endovascularrobotics. Learn more here: https://t.co/tycQQZBnIE

Did you hear? Following the successful completion of our Pivotal Human Clinical Trial, U.S. submission of LIBERTY® to the Food and Drug Administration is expected by the end of 2024. https://t.co/yczV3ljiSM #FDASubmission $MBOT #endovascularrobotics

Harel Gadot, MBOT CEO, President and Chairman, will join an expert panel for #SRS2025 PLENARY 5: ENDOVASCULAR on Saturday, July 19, 2025, 1:30-3:30 pm. Click here to register: https://t.co/CtqMlIQV3s #MBOTnews #endovascularrobotics

#MBOT continues to strengthen its commercial capabilities in preparation for the anticipated launch of LIBERTY® Endovascular Robotic System in Q3 2025. More here: https://t.co/LGBlDOjph8 #InvestorNews #MedicalRobotics #EndovascularRobotics

We’re excited to connect face-to-face with the world’s leading #RoboticSurgery experts at this year’s #SRS2025 program! Will you be joining us? https://t.co/CtqMlIQV3s #EndovascularRobotics

Here's a timeless webinar from CEO & Founder Harel Gadot about the advancement of single-use robotic systems in endovascular procedures, which is still on point today. https://t.co/LuNsGxLvol #endovascularrobotics

According to @LA Times, "Endovascular surgery benefits from robotic assistance by allowing catheter-based procedures with small incisions." Microbot is focused on revolutionizing #endovascularrobotics. Read more: #HealthTech https://t.co/RGH93VXyV7

Update on $MBOT’s Pivotal Human Clinical Trial. Microbot Medical expects to complete the trial earlier than anticipated as 80% of patients have completed follow up. Read more here: https://t.co/Y09rcR3Ic6 #EndovascularRobotics #MedicalDevice #MedTech